Provided by Tiger Trade Technology Pte. Ltd.

CH BIOTECH SER

0.770
+0.0202.67%
Volume:680.00K
Turnover:502.80K
Market Cap:751.31M
PE:-3.76
High:0.770
Open:0.720
Low:0.720
Close:0.750
52wk High:1.330
52wk Low:0.340
Shares:975.73M
HK Float Shares:975.73M
Volume Ratio:0.84
T/O Rate:0.07%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.205
ROE:-54.91%
ROA:-8.08%
PB:3.14
PE(LYR):-3.76
PS:9.77

Loading ...

CH BIOTECH SER Reports 2025 Fiscal Year Results: Shareholder Loss Narrows by 65.3%

Stock News
·
Yesterday

CH BIOTECH SER FY2025 Loss Narrows by 67.9%; Revenue Rises, BNCT Center Set for 2026 Trial Operations

Bulletin Express
·
Mar 27

China Biotech Services - FY Loss Attributable HK$68.8 Mln

THOMSON REUTERS
·
Mar 27

China Biotech Services FY2025 operating loss narrows to HK$52 million; revenue rises 4.2% to HK$74 million

Reuters
·
Mar 27

Milestone Achievement: Hainan Successfully Conducts First BNCT Treatment

Stock News
·
Mar 23

CH BIOTECH SER (08037) Schedules Board Meeting on 27 March 2026 to Review Annual Results

Bulletin Express
·
Mar 06

CH Biotech Ser (08037) Announces Potential Net Loss Reduction for FY2025

Bulletin Express
·
Mar 06

CH BIOTECH SER Anticipates 60% Reduction in Net Loss for 2025 Fiscal Year

Stock News
·
Mar 06

China Biotech Services - Expected Result Due to Receipt of HK$14 Mln Insurance Compensation in FY for Hainan Site Damages, Others

THOMSON REUTERS
·
Mar 06

China Biotech Services - Expects FY2025 Net Loss of Not More Than HK$100 Mln

THOMSON REUTERS
·
Mar 06

China Biotech Services forecasts FY2025 net loss at no more than HK$100 million

Reuters
·
Mar 06

CH BIOTECH SER (08037) Reports February 2026 Monthly Return on Share Capital and Convertible Bonds

Bulletin Express
·
Mar 04

CH BIOTECH SER Finalizes $35 Million Convertible Bond Offering

Stock News
·
Feb 23

China Biotech Services (8037) Announces Completion of US$35.00 million Convertible Bond Issue and Adjustments to 2024 Convertible Bonds

Bulletin Express
·
Feb 23

China Biotech Services Completes US$35 Million Convertible Bond Issue

Reuters
·
Feb 23

China's First Approved BNCT Treatment Center Begins Trial Operation in Hainan, CH BIOTECH SER (08037) Poised for Valuation Reassessment

Stock News
·
Feb 09

China Biotech Services (8037) Announces Approval of Convertible Bond Issue at SGM

Bulletin Express
·
Feb 05

China Biotech Services Holdings Ltd. Held Special General Meeting

Reuters
·
Feb 05

China Biotech Services Holdings Ltd. to Vote on Proposed Issue of Convertible Bonds at Upcoming Shareholder Meeting

Reuters
·
Jan 22

CH BIOTECH SER (08037) Introduces Strategic Investor Mr. Gong Hongjia, Ushering in a New Chapter of Industrial Synergy and Secondary Growth

Stock News
·
Dec 31, 2025